There are no active IND applications or FDA-registered human clinical trials for BPC-157
10.1038/s41467-025-60844-9 8 BoutouyrieP.ChowienczykP.HumphreyJ
We utilised a global proteomics phosphoantibody array approach to identify further c-MET/HGF signal transduction intermediates in SCLC
Epithalon Benefits | Clinical Trials Epithalon is classified as a research chemical outside of Russia, where it is used to treat menopause-related symptoms, anovulatory infertility, and hormone-dependent tumors [9]
This provides a sustained signal that primes the pituitary for a prolonged period of GH release, deeply supporting long-term physiological regulation

References Nature Medicine (2014) Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity PMC (2024) Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunctions Frontiers in Pharmacology (2024) NNMT: a novel therapeutic target for metabolic syndrome PubMed (2021) LC-MS/MS assay for 5-amino-1-methylquinolinium: pharmacokinetic and oral bioavailability study ResearchGate (2021) Combined NNMT inhibition and reduced-calorie diet normalizes body composition in obese mice PMC (2022) Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice NMN.com / Scientific Reports Role of NNMT inhibition in muscle strength: enhanced grip strength with exercise Swolverine 5-Amino-1MQ mechanism, benefits, stacking and cycling guide PMC Subcutaneous drug injection review: pharmacologic considerations CDC Vaccine administration: subcutaneous route (angle/site